Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NaPi2b is a sodium-dependent phosphate transporter protein that plays a crucial role in maintaining phosphate homeostasis by mediating the active transport of inorganic phosphate into cells. It is expressed in various tissues, including the lung, small intestine, salivary glands, mammary glands, liver, and kidney. NaPi2b is significantly overexpressed in several human cancers, including ovarian, lung, thyroid, and breast cancers, making it a promising therapeutic target for antibody-drug conjugates. Inhibition of NaPi2b expression has been shown to suppress tumor growth and proliferation, and promote apoptosis.
Antibody-drug conjugates targeting NaPi2b to deliver cytotoxic payloads to cancer cells
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent phosphate transporter protein 2B (NaPi2b).